NEW YORK and TORONTO and
HERZLIYA, Israel, Sept. 8, 2021 /PRNewswire/ -- InterCure Ltd.
(NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure"
or the "Company") today announced that Alexander Rabinovitch, CEO of InterCure, will
present live at VirtualInvestorConferences.com on September 9th.
DATE: September 9th,
2021
TIME: 11:30 AM
ET
LINK: https://bit.ly/3ylJi2m
This will be a live, interactive online event where investors
are invited to ask the Company questions in real-time. If attendees
are not able to join the event live on the day of the conference,
an archived webcast will also be made available after the
event.
It is recommended that investors pre-register and run the online
system check to expedite participation and receive event
updates.
Learn more about the event at
www.virtualinvestorconferences.com.
Recent Company Highlights
- InterCure is the leading, profitable and fastest growing
vertically integrated medical cannabis operator outside of
North America
-
- Canndoc, a wholly owned subsidiary of InterCure, is
Israel's largest licensed cannabis
producer
- Focus on pharmaceutical-grade, GMP-certified branded
products
- Branded product offerings with 100% retail penetration
- The Company's common shares commenced trading September 1, 2021, on The NASDAQ Global Market
under the ticker symbol "INCR"
- Recorded Q2 '21 revenue growth of 4 times YoY and 37%
sequentially
- Recently signed an agreement in which InterCure will purchase
strategic assets from Cannomed, an Israel-based company and owner of a pharmacy
chain specializing in dispensing medical cannabis
About InterCure (dba Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE:
INCR) is the leading, profitable, and fastest growing cannabis
company outside of North America.
Canndoc, a wholly owned subsidiary of InterCure, is Israel's largest licensed cannabis producer
and one of the first to offer Good Manufacturing Practices (GMP)
certified and pharmaceutical-grade medical cannabis products.
InterCure leverages its market leading distribution network, best
in class international partnerships and a high-margin vertically
integrated "seed-to-sale" model to lead the fastest growing
cannabis global market outside of North
America.
For more information, visit: http://www.intercure.co
About InterCure (dba Canndoc)
InterCure (dba Canndoc) (TSX:INCR.U, TASE:INCR) is the
leading, fastest growing and the most profitable cannabis company
outside of North America. Canndoc,
a wholly owned subsidiary of InterCure, is Israel's largest licensed cannabis producer
and one of the first to offer Good Manufacturing Practices (GMP)
certified and pharmaceutical-grade medical cannabis products.
InterCure leverages its market leading distribution network, best
in class international partnerships and a high-margin vertically
integrated "seed-to-sale" model to be the most profitable cannabis
company globally outside of North
America
About Virtual Investor Conferences
Virtual Investor Conferences (VIC) is the leading proprietary
investor conference series that provides an interactive forum for
publicly-traded companies to meet and present directly with
investors.
A real-time solution for investor engagement, Virtual Investor
Conferences is part of OTC Market Group's suite of investor
relations services specifically designed for more efficient
Investor Access. Replicating the look and feel of on-site
investor conferences, Virtual Investor Conferences combine
leading-edge conferencing and investor communications capabilities
with a comprehensive global investor audience network.
Forward-Looking Statements
This press release may contain forward-looking information
within the meaning of applicable securities legislation, which
reflects InterCure's current expectations regarding future events.
The words "will", "expects", "intends" and similar expressions are
often intended to identify forward-looking information, although
not all forward-looking information contains these identifying
words. Specific forward-looking information contained in this press
release includes, but is not limited to: the success of the
acquisition of Cannomed assets and the future outcomes of such
acquisition, the success of the future partnership between the
Company and Cannomed, the Company's future revenue growth and
results, the success of its global expansion plans, its continued
growth, the expected operations, financial results, business
strategy, competitive strengths, goals and expansion and growth
plans and the expansion strategy to major markets worldwide.
Forward-looking information is based on a number of assumptions and
is subject to a number of risks and uncertainties, many of which
are beyond InterCure's control, which could cause actual results
and events to differ materially from those that are disclosed in or
implied by such forward-looking information. Such risks and
uncertainties include, but are not limited to: changes in general
economic, business and political conditions, changes in applicable
laws, the Canadian regulatory landscapes and enforcement related to
cannabis, changes in public opinion and perception of the cannabis
industry, reliance on the expertise and judgment of senior
management, as well as the factors discussed under the heading
"Risk Factors" " and "Cautionary Note Regarding Forward-Looking
Statements" in the registration statement on Form 20-F, filed with
the Securities Exchange Commission on August
16, 2021. InterCure undertakes no obligation to update such
forward-looking information, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/intercure-to-webcast-live-at-virtualinvestorconferencescom-september-9th-301371450.html
SOURCE VirtualInvestorConferences.com